Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Onur Ertik, Umar Faruk Magaji, Ozlem Sacan & Refiye Yanardag. (2023) Effect of Moringa oleifera leaf extract on valproate-induced oxidative damage in muscle. Drug and Chemical Toxicology 46:6, pages 1212-1222.
Read now
Read now
Alessandra Morano, Luigi Iannone, Caterina Palleria, Martina Fanella, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opinion on Pharmacotherapy 20:1, pages 25-39.
Read now
Read now
Kevin Cronin, Hernando Escobar, Karoly Szekeres, Eduardo Reyes-Vargas, Alan L. Rockwood, Mark C. Lloyd, Julio C. Delgado & George Blanck. (2013) Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. Human Vaccines & Immunotherapeutics 9:4, pages 784-789.
Read now
Read now
Natalia Lampon & J. Carlos Tutor. (2012) Apparent clearance of valproic acid in elderly epileptic patients: estimation of the confounding effect of albumin concentration. Upsala Journal of Medical Sciences 117:1, pages 41-46.
Read now
Read now
Natalia Lampon & J. Carlos Tutor. (2011) A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid. Upsala Journal of Medical Sciences 116:2, pages 148-154.
Read now
Read now
Articles from other publishers (70)
Alejandra Schiavo, Cecilia Maldonado, Marta Vázquez, Pietro Fagiolino, Iñaki F. Trocóniz & Manuel Ibarra. (2023) Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation. European Journal of Pharmaceutical Sciences 183, pages 106399.
Crossref
Crossref
Fructuoso Ayala-Guerrero, Daniel Castro-Domínguez, Erik L. Mateos-Salgado, Graciela Mexicano-Medina & Carlos Alberto Gutiérrez-Chávez. (2023) Effect of valproate on sleep patterns disturbed by epilepsy. Physiology & Behavior 259, pages 114054.
Crossref
Crossref
Yutaka Ikeda, Yuya Tajika & Yukio Nagasaki. (2022)
Design of self-assembling anti-epileptic drug for long-acting drug delivery
in vivo
. Biomaterials Science 10:21, pages 6307-6314.
Crossref
Crossref
R. Jover, P. Soluyanova, E. Moro-Castaño, M. Moreno-Torres, A.V. Marco-Hernández, M. Tomas-Vila & J.V. Castell. (2022) SOC-V-11 New serum miRNA biomarkers to predict liver steatosis by valproic acid in paediatric epileptic patients. Toxicology Letters 368, pages S68.
Crossref
Crossref
Sing Teang Kong, Hai-Shu Lin, Jianhong Ching, Huiqing Xie & Paul C. Ho. (2022) Dried Blood Spots as Matrix for Evaluation of Valproate Levels and the Immediate and Delayed Metabolomic Changes Induced by Single Valproate Dose Treatment. International Journal of Molecular Sciences 23:13, pages 7083.
Crossref
Crossref
Sebile AZİRAK, Sedat BİLGİÇ, Deniz TAŞTEMİR KORKMAZ, Murat SEVİMLİ & Mehmet Kaya ÖZER. (2022) Timokinon’un sıçanların pankreas dokusunda valproik asidin neden olduğu hasarı iyileştirmeye etkisiEffect of thymoquinone on ameliorating valproic acid-induced damage in pancreatic tissue of rats. Cukurova Medical Journal 47:1, pages 350-359.
Crossref
Crossref
Raymond Price, Don Smith, Gary Franklin, Gary Gronseth, Michael Pignone, William S. David, Carmel Armon, Bruce A. Perkins, Vera Bril, Alexander Rae-Grant, John Halperin, Nicole Licking, Mary Dolan O'Brien, Scott R. Wessels, Leslie C. MacGregor, Kenneth Fink, Lawrence B. Harkless, Lindsay Colbert & Brian C. Callaghan. (2021) Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary. Neurology 98:1, pages 31-43.
Crossref
Crossref
Kursat Bora Carman, Kursad Aydın, Betul Kilic Aydin, Ali Cansu, Meltem Cobanogullari Direk, Selver Durmus, Nihal Olgaç Dündar, Pinar Gencpinar, Serdal Gungor, Esra Gurkas, Ozgen Hur, Meral Karadag, Cefa Nil Karademir, Pinar Ozkan Kart, Cetin Okuyaz, Nefise Arıbas Oz, Yakup Peduk, Huseyin Per, Mine Hepsen Serin, Hasan Tekgul, Bulent Unay, Coskun Yarar & Gonca Kilic Yildirim. (2022) Evaluation of micronutrient levels in children with cerebral palsy. Pediatrics International 64:1.
Crossref
Crossref
Tatiani Soultana Ilia, Pinelopi Dragoumi, Stavroula Papanikolopoulou, Dimitrios G. Goulis, Evangelos Pavlou & Dimitrios Zafeiriou. (2022) Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis. Seizure 94, pages 117-125.
Crossref
Crossref
Francesca Marchese, Simona Cappelletti, Melissa Filippini, Cristiana Alessia Guido, Claudia Passamonti, Barbara Pucci, Michela Sole & Pasquale Striano. (2021) Comorbidities in Dravet Syndrome and Lennox–Gastaut Syndrome. SN Comprehensive Clinical Medicine 3:10, pages 2167-2179.
Crossref
Crossref
Bertram Pitt, Nadia R. Sutton, Zhong Wang, Sascha N. Goonewardena & Michael Holinstat. (2021) Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19. European Journal of Pharmacology 898, pages 173988.
Crossref
Crossref
Kang-Hoon Kim, Ji Hoon Jung, Won-Seok Chung, Chang-Hun Lee & Hyeung-Jin Jang. (2021) Ferulic Acid Induces Keratin 6α via Inhibition of Nuclear β-Catenin Accumulation and Activation of Nrf2 in Wound-Induced Inflammation. Biomedicines 9:5, pages 459.
Crossref
Crossref
Laura María Palomino Pérez, Álvaro Martín‐Rivada, Elvira Cañedo Villaroya, Juan José García‐Peñas, Margarita Cuervas‐Mons Vendrell & Consuelo Pedrón‐Giner. (2020) Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases. JIMD Reports 55:1, pages 3-11.
Crossref
Crossref
Kenneth A. Myers, Uzziel Tamon, Ramanakumar V. Agnihotram & Saoussen Berrahmoune. (2020) Serum Levels of Valproic Acid and Carbamazepine Do Not Correlate Well with End-Organ Dysfunction. Epilepsy Research 163, pages 106343.
Crossref
Crossref
Jessica Elena Mendieta-Wejebe, Arianna Silva-Trujillo, Martiniano Bello, Humberto L Mendoza-Figueroa, Norma Lizeth Galindo-Alvarez, Arnulfo Albores, Feliciano Tamay-Cach, Martha Cecilia Rosales-Hernández, Aurelio Romero-Castro & José Correa-Basurto. (2020)
Exploring the biotransformation of
N
-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using
in silico
predictions and
in vitro
studies
. Journal of Pharmacy and Pharmacology 72:7, pages 938-955.
Crossref
Crossref
Wei Liu, Xiang Shang, Shuyong Yao & Feng Wang. (2019) A novel and nonderivatization method for the determination of valproic acid in human serum by two‐dimensional liquid chromatography. Biomedical Chromatography 34:1.
Crossref
Crossref
Michael G. Leeming, Noel Cranswick, Christine E. Wright, James Ziogas, Terence J. O'Brien, William A. Donald & Richard A.J. O'Hair. (2019) Using high-resolution Twin-Ion Metabolite Extraction (HiTIME) mass spectrometry with stable isotope labelling to investigate the metabolism of valproic acid in vivo. International Journal of Mass Spectrometry 444, pages 116187.
Crossref
Crossref
Brenno Mazzariol, Antonella Pastorini, Alessandro di Luca & Natale Mario di Luca. (2019) Recent Medico-Legal Developments on the Issue of Epilepsy and Driver’s License Requirements in the Italian and European Legislation. Behavioural Neurology 2019, pages 1-5.
Crossref
Crossref
Shabir Ahmad GanaiShabir Ahmad Ganai. 2019. Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders. Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders
39
58
.
Claire ZimmermanEric Yarnell. (2018) Herbal Medicines for Seizures. Alternative and Complementary Therapies 24:6, pages 281-290.
Crossref
Crossref
Reza Shervin Badv, Arash Abbasi, Mahmoud Reza Ashrafi, Fakhreddin Shariatmadari & Omid Bayat. (2018) The Effect of Sodium Valproate on Urinary Frequency and Enuresis Compared to Carbamazepine in Children with Epilepsy. Iranian Journal of Pediatrics In Press:In Press.
Crossref
Crossref
Byoung-San Moon, Wange Lu & Hong Ju Park. (2018) Valproic acid promotes the neuronal differentiation of spiral ganglion neural stem cells with robust axonal growth. Biochemical and Biophysical Research Communications 503:4, pages 2728-2735.
Crossref
Crossref
Thomas Efferth, Ursula Schöttler, Sanjeev Krishna, Peter Schmiedek, Frederik Wenz & Frank A. Giordano. (2016) Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature. Archives of Toxicology 91:4, pages 1833-1846.
Crossref
Crossref
Abdalla M. El-Mowafy, Mohamed M. Katary, Chelsey Pye, Ahmed S. Ibrahim & Ahmed A. Elmarakby. (2016) Novel molecular triggers underlie valproate-induced liver injury and its alleviation by the omega-3 fatty acid DHA: role of inflammation and apoptosis. Heliyon 2:7, pages e00130.
Crossref
Crossref
Martha Spilioti, Evangelos Pavlou, Maria Gogou, Irene Katsanika, Efimia Papadopoulou-Alataki, Olga Grafakou, Anastasia Gkampeta, Argyrios Dinopoulos & Athanasios Evangeliou. (2016) Valproate effect on ketosis in children under ketogenic diet. European Journal of Paediatric Neurology 20:4, pages 555-559.
Crossref
Crossref
Ashfaqul Hoque, M. Iqbal Hossain, S. Sadia Ameen, Ching-Seng Ang, Nicholas Williamson, Dominic C.H. Ng, Anderly C. Chueh, Carli Roulston & Heung-Chin Cheng. (2016) A beacon of hope in stroke therapy—Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Pharmacology & Therapeutics 160, pages 159-179.
Crossref
Crossref
Bozena Kaminska, Mariana Mota & Marina Pizzi. (2016) Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:3, pages 339-351.
Crossref
Crossref
Sebastian Weise, Steffen Syrbe, Matthias Preuss, Astrid Bertsche, Andreas Merkenschlager & Matthias K Bernhard. (2015) Pronounced reversible hyperammonemic encephalopathy associated with combined valproate–topiramate therapy in a 7-year-old girl. SpringerPlus 4:1.
Crossref
Crossref
John A Halsall, Nil Turan, Maaike Wiersma & Bryan M Turner. (2015) Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response. Epigenetics & Chromatin 8:1.
Crossref
Crossref
Francesca Penagini, Chiara Mameli, Valentina Fabiano, Domenica Brunetti, Dario Dilillo & Gian Zuccotti. (2015) Dietary Intakes and Nutritional Issues in Neurologically Impaired Children. Nutrients 7:11, pages 9400-9415.
Crossref
Crossref
Vincenza Sofo, Martin Götte, Antonio Simone Laganà, Francesca Maria Salmeri, Onofrio Triolo, Emanuele Sturlese, Giovanni Retto, Maria Alfa, Roberta Granese & Mauricio Simões Abrão. (2015) Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Archives of Gynecology and Obstetrics 292:5, pages 973-986.
Crossref
Crossref
Lin Guo, Yanke Chen, Rui Zhao, Guanghui Wang, Eitan Friedman, Ao Zhang & Xuechu Zhen. (2015) Allosteric modulation of sigma-1 receptors elicits anti-seizure activities. British Journal of Pharmacology 172:16, pages 4052-4065.
Crossref
Crossref
Rutger J. Wierda, Marieke Goedhart, Marja C.J.A. van Eggermond, Alice F. Muggen, Xanne M. Miggelbrink, Sacha B. Geutskens, Erik van Zwet, Geert W. Haasnoot & Peter J. van den Elsen. (2015) A role for KMT1c in monocyte to dendritic cell differentiation. Human Immunology 76:6, pages 431-437.
Crossref
Crossref
Soo-Kyoung Kim, Sung-Pa Park & Oh-Young Kwon. (2015) Impact of depression and anxiety on adverse event profiles in Korean people with epilepsy. Epilepsy & Behavior 46, pages 185-191.
Crossref
Crossref
Nesibe Taşer & Murat Sarıkaya. (2015) An unusual case of pleuropericardial neutrophilic effusion associated with valproate. Journal of the Formosan Medical Association 114:4, pages 375-376.
Crossref
Crossref
Eric J. James, Jenny Gu, Carolina M. Ramirez-Vizcarrondo, Mashfiq Hasan, Torrey L.S. Truszkowski, Yuqi Tan, Phouangmaly M. Oupravanh, Arseny S. Khakhalin & Carlos D. Aizenman. (2015)
Valproate-Induced Neurodevelopmental Deficits in
Xenopus laevis
Tadpoles
. The Journal of Neuroscience 35:7, pages 3218-3229.
Crossref
Crossref
Edoardo Farinelli. (2015) Valproic acid and nonalcoholic fatty liver disease: A possible association?. World Journal of Hepatology 7:9, pages 1251.
Crossref
Crossref
Jin-Feng Zhang, Zhi-Qing Zhang, Wei-Chong Dong & Ye Jiang. (2014) A New Derivatization Method to Enhance Sensitivity for the Determination of Low Levels of Valproic Acid in Human Plasma. Journal of Chromatographic Science 52:10, pages 1173-1180.
Crossref
Crossref
Gonçalo Castelo-Branco, Pernilla Stridh, André Ortlieb Guerreiro-Cacais, Milena Z. Adzemovic, Ana Mendanha Falcão, Monica Marta, Rasmus Berglund, Alan Gillett, Kedir Hussen Hamza, Hans Lassmann, Ola Hermanson & Maja Jagodic. (2014) Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats. Neurobiology of Disease 71, pages 220-233.
Crossref
Crossref
Niki Katsiki, Dimitri P. Mikhailidis & Devaki R. Nair. (2014) The effects of antiepileptic drugs on vascular risk factors: A narrative review. Seizure 23:9, pages 677-684.
Crossref
Crossref
Erling P. Larsen & John R. Østergaard. (2014) Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease). Seizure 23:6, pages 429-434.
Crossref
Crossref
Ulziisaikhan Jambalganiin, Bilegtsaikhan Tsolmongyn, Naoki Koide, Erdenezaya Odkhuu, Yoshikazu Naiki, Takayuki Komatsu, Tomoaki Yoshida & Takashi Yokochi. (2014) A novel mechanism for inhibition of lipopolysaccharide-induced proinflammatory cytokine production by valproic acid. International Immunopharmacology 20:1, pages 181-187.
Crossref
Crossref
Elsa Boudadi, Hannah Stower, John A Halsall, Charlotte E Rutledge, Martin Leeb, Anton Wutz, Laura P O’Neill, Karl P Nightingale & Bryan M Turner. (2013) The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing. Epigenetics & Chromatin 6:1.
Crossref
Crossref
J-Y Yoon, D Szwajcer, G Ishdorj, P Benjaminson, W Xiao, R Kumar, J B Johnston & S B Gibson. (2013) Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B. Blood Cancer Journal 3:10, pages e153-e153.
Crossref
Crossref
Jayakumar Surendradoss, András Szeitz, Xiao Wei Teng, Thomas K.H. Chang & Frank S. Abbott. (2013) A rapid and sensitive assay to quantify valproyl 1-O-acyl glucuronide in supernatants of sandwich-cultured rat hepatocytes using ultra-high performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 932, pages 40-49.
Crossref
Crossref
Claude Abdallah. (2013) Valproic acid and acquired coagulopathy. Pediatric Anesthesia 23:7, pages 674-675.
Crossref
Crossref
Bilegtsaikhan Tsolmongyn, Naoki Koide, Erdenezaya Odkhuu, Abedul Haque, Yoshikazu Naiki, Takayuki Komatsu, Tomoaki Yoshida & Takashi Yokochi. (2013) Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation. Cellular Immunology 282:2, pages 100-105.
Crossref
Crossref
Rutger Wierda & Peter van den Elsen. (2012) Genetic and Epigenetic Regulation of CCR5 Transcription. Biology 1:3, pages 869-879.
Crossref
Crossref
Wenzhi Wang, Jianzhong Wu, Shichuo Li, Xiaojuan Ru, Jinou Zheng, Suiqiang Zhu & Josemir W. Sander. (2012) Sodium valproate for epilepsy in rural China: An efficacy and safety assessment in primary care. Epilepsy Research 102:3, pages 201-205.
Crossref
Crossref
Jayakumar Surendradoss, Thomas K.H. Chang & Frank S. Abbott. (2012) Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes. Toxicology and Applied Pharmacology 264:3, pages 413-422.
Crossref
Crossref
Dorota Haznar-Garbacz, Grzegorz Garbacz, Friederike Eisenächer, Sandra Klein & Werner Weitschies. (2012) A novel liquefied gas based oral controlled release drug delivery system for liquid drug formulations. European Journal of Pharmaceutics and Biopharmaceutics 81:2, pages 334-338.
Crossref
Crossref
Claudio NapoliValeria CrudeleAndrea SoricelliMohammed Al-OmranNicoletta VitaleTeresa InfanteFrancesco P. Mancini. (2012) Primary Prevention of Atherosclerosis. Circulation 125:19, pages 2363-2373.
Crossref
Crossref
E McCormack, I Haaland, G Venås, R B Forthun, S Huseby, G Gausdal, S Knappskog, D R Micklem, J B Lorens, Ø Bruserud & B T Gjertsen. (2011) Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. Leukemia 26:5, pages 910-917.
Crossref
Crossref
Zhuo-jia Chen, Xue-ding Wang, Hong-sheng Wang, Shu-da Chen, Lie-min Zhou, Jia-li Li, Wen-ying Shu, Jue-qian Zhou, Zi-yan Fang, Yu Zhang & Min Huang. (2012) Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy. Seizure 21:2, pages 110-117.
Crossref
Crossref
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
419
460
.
C. Napoli, T. Infante & A. Casamassimi. (2011) Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage. Cardiovascular Research 92:3, pages 367-374.
Crossref
Crossref
Dipender Gill, Sheena Derry, Philip J Wiffen & R Andrew Moore. (2011) Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jacqueline A. French & Deana M. Gazzola. (2011) New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?. Therapeutic Advances in Drug Safety 2:4, pages 141-158.
Crossref
Crossref
Ilaria Burba, Gualtiero I. Colombo, Lidia Irene Staszewsky, Marco De Simone, Paolo Devanna, Simona Nanni, Daniele Avitabile, Fabiola Molla, Simona Cosentino, Ilaria Russo, Noeleen De Angelis, Annarita Soldo, Antonella Biondi, Elisa Gambini, Carlo Gaetano, Antonella Farsetti, Giulio Pompilio, Roberto Latini, Maurizio C. Capogrossi & Maurizio Pesce. (2011) Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34+ Cells. PLoS ONE 6:7, pages e22158.
Crossref
Crossref
Claudio Napoli, Amelia Casamassimi, Valeria Crudele, Teresa Infante & Ciro Abbondanza. (2011) Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework. Future Cardiology 7:4, pages 485-497.
Crossref
Crossref
Charles A. Dinarello, Gianluca Fossati & Paolo Mascagni. (2011) Histone Deacetylase Inhibitors for Treating a Spectrum of Diseases Not Related to Cancer. Molecular Medicine 17:5-6, pages 333-352.
Crossref
Crossref
Leo A B Joosten, Flavio Leoni, Sajeda Meghji & Paolo Mascagni. (2011) Inhibition of HDAC Activity by ITF2357 Ameliorates Joint Inflammation and Prevents Cartilage and Bone Destruction in Experimental Arthritis. Molecular Medicine 17:5-6, pages 391-396.
Crossref
Crossref
Na’ama A Shein & Esther Shohami. (2011) Histone Deacetylase Inhibitors as Therapeutic Agents for Acute Central Nervous System Injuries. Molecular Medicine 17:5-6, pages 448-456.
Crossref
Crossref
Eli C Lewis, Lykke Blaabjerg, Joachim Størling, Sif G Ronn, Paolo Mascagni, Charles A Dinarello & Thomas Mandrup-Poulsen. (2011) The Oral Histone Deacetylase Inhibitor ITF2357 Reduces Cytokines and Protects Islet β Cells In Vivo and In Vitro. Molecular Medicine 17:5-6, pages 369-377.
Crossref
Crossref
Gang Wu, Changlong Nan, Johnathon C Rollo, Xupei Huang & Jie Tian. (2010) Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase. Journal of Biomedical Science 17:1.
Crossref
Crossref
Rutger J. Wierda, Sacha B. Geutskens, J. Wouter Jukema, Paul H.A. Quax & Peter J. van den Elsen. (2010) Epigenetics in atherosclerosis and inflammation. Journal of Cellular and Molecular Medicine 14:6a, pages 1225-1240.
Crossref
Crossref
Charles A. Dinarello. (2010) Anti-inflammatory Agents: Present and Future. Cell 140:6, pages 935-950.
Crossref
Crossref
Na'ama A. Shein, Nikolaos Grigoriadis, Alexander G. Alexandrovich, Constantina Simeonidou, Athanasios Lourbopoulos, Eleni Polyzoidou, Victoria Trembovler, Paolo Mascagni, Charles A. Dinarello & Esther Shohami. (2009) Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. The FASEB Journal 23:12, pages 4266-4275.
Crossref
Crossref
Natalia N. Nalivaeva, Nikolai D. Belyaev & Anthony J. Turner. (2009) Sodium valproate: an old drug with new roles. Trends in Pharmacological Sciences 30:10, pages 509-514.
Crossref
Crossref
K. N. Woodward. 2009. Veterinary Pharmacovigilance. Veterinary Pharmacovigilance
423
452
.